Business
ZYUS Announces Delay in Its Annual Filings
ZYUS Announces Delay in Its Annual Filings Canada NewsWire /NOT FOR DISTRIBUTION T...
About this update from Zyus Life Sciences Corporation
[{"type":"text","content":"\n\n\nZYUS Announces Delay in Its Annual Filings\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nCanada NewsWire\n\n\n/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/SASKATOON, SK, April 30, 2026 /CNW/ - ZYUS Life Sciences Corporation (the \"Company\") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, today announces that it will be delayed in completing its audit of the Company's audited annual financial statements, the related management's discussion and analysis, and the accompanying chief executive officer and chief financial officer certification for its financial year ended December 31, 2025 (collectively, the \"Annual Filings\"). As a result of this delay, the Annual Filings will not be finalized on April 30, 2026 (the \"Filing Deadline\"), as required under Parts 4 and 5 of National Instrument 51-102 – Continuous Disclosure Obligations and National Instrument 52-109 – Certification of Disclosure in Issuers' Annual and Interim Filings.By not filing the Annual Filings by the Filing Deadline, the Ontario Securities Commission (the \"OSC\") may impose a failure-to-file-cease-trade-order (\"CTO\") pursuant to National Policy 11-207. A CTO would prohibit the trading by any person of any securities of the Company in Canada, including trades in the Company's common shares made through the TSX Venture Exchange. If issued, the CTO would remain in place until revoked by the OSC.The delay in completing and filing the Annual Filings is due to the additional time required to complete accounting and audit procedures for various complex accounting matters, including the valuation of certain of the Company's physical assets. The Company does not anticipate the results of the assessment of these physical assets to impact the Company's potential future cashflow. The Company believes the principal accounting issues have been addressed and conti...